Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Commentary - Journal of Cancer Immunology & Therapy (2022) Volume 5, Issue 5

Agoraphobic diagnosis of breast cancer and detection of breast cancer cells

Breast cancer is the leading cause of cancer-related morbidity and mortality in women worldwide. Early diagnosis and effective treatment of all types of cancer are critical for a good prognosis. Patients with smaller tumor sizes at diagnosis have significantly higher survival rates and significantly less likely to have their cancer fatal. Therefore, many new techniques for early detection of primary tumors, distant metastases and recurrent disease are being developed for effective breast cancer therapy. Theranostics are emerging as a new paradigm for simultaneous diagnosis, imaging, and treatment of cancer. It has the potential to provide timely and enhanced patient care through personalized treatment. Nanotheranostics enable the embedding of cell-specific targeting moieties, imaging agents, and therapeutic agents into a single formulation for effective therapy.

Author(s): Sofia Daniel

Abstract Full Text PDF

Get the App